Rationale for specific allergen testing of patients with asthma in the clinical pulmonary office setting

Chest

Volumn 147, Issue 1, 2015, Pages 251-258

  Schulman, Edward S ^a   Pohlig, Carol ^b  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGEN; IMMUNOGLOBULIN E ANTIBODY;

ALLERGY TEST; ANTIBODY DETECTION; ARTICLE; ASTHMA; DIAGNOSTIC TEST ACCURACY STUDY; ENVIRONMENTAL EXPOSURE; FALSE NEGATIVE RESULT; FALSE POSITIVE RESULT; HUMAN; INTERMETHOD COMPARISON; INTRACUTANEOUS TEST; PRICK TEST; PROTEIN FUNCTION; RADIOALLERGOSORBENT TEST; REPRODUCIBILITY; SAFETY; SENSITIVITY AND SPECIFICITY; TURNAROUND TIME; AMBULATORY CARE; DIAGNOSTIC USE; IMMUNOLOGY; PROCEDURES; SKIN TEST;

ALLERGENS; AMBULATORY CARE; ASTHMA; HUMANS; SKIN TESTS;

EID: 84920722676     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.12-0072     Document Type: Article

References (39)

1. Asthma statistics. American Academy of Allergy, Asthma & Immunology website. http://www.aaaai.org/about-the-aaaai/newsroom/asthma-statistics.aspx. Accessed December 20, 2012.
2. Burrows B, Martinez FD, Halonen M, Barbee RA, Cline MG. Association of asthma with serum IgE levels and skin-test reactivity to allergens. N Engl J Med. 1989; 320 (5): 271-277.
3. Novak N, Bieber T. Allergic and nonallergic forms of atopic diseases. J Allergy Clin Immunol. 2003; 112 (2): 252-262.
4. Williams PB, Ahlstedt S, Barnes JH, Söderström L, Portnoy J. Are our impressions of allergy test performances correct? Ann Allergy Asthma Immunol. 2003; 91 (1): 26-33.
5. Crystal-Peters J, Neslusan C, Crown WH, Torres A. Treating allergic rhinitis in patients with comorbid asthma: the risk of asthma-related hospitalizations and emergency department visits. J Allergy Clin Immunol. 2002; 109 (1): 57-62.
6. Carter ER, Pulos E, Delaney J, Matheson EJ, Moffitt DR. Allergy history does not predict skin test reactivity in asthmatic children. J Asthma. 2000; 37 (8): 685-690.
7. Platts-Mills TA. The role of immunoglobulin E in allergy and asthma. Am J Respir Crit Care Med. 2001; 164 (8 pt 2): S1 - S5.
8. Schulman ES. Development of a monoclonal anti-immunoglobulin Eantibody (omalizumab) for the treatment of allergic respiratory disorders. Am J Respir Crit Care Med. 2001; 164 (8 pt 2): S6 - S11.
9. Schulman ES, Sporn P. Mast cells and eosinophils. In: Fishman AP, Elias JA, Fishman JA, et al, eds. Fishman's Pulmonary Diseases and Disorders. New York, NY : McGraw Hill; 2008 : 309-329.
10. Ishizaka K, Ishizaka T. Physicochemical properties of reaginic antibody. 1. Association of reaginic activity with an immunoglobulin other than gamma A- or gamma G-globulin. J Allergy. 1966; 37 (3): 169-185.
11. Johansson SG, Bennich H. Immunological studies of an atypical (myeloma) immunoglobulin. Immunology. 1967; 13 (4): 381-394.
12. Holgate S, Casale T, Wenzel S, Bousquet J, Deniz Y, Reisner C. The anti-inflammatory effects of omalizumab confirm the central role of IgE in allergic inflammation. J Allergy Clin Immunol. 2005; 115 (3): 459-465.
13. Djukanović R, Wilson SJ, Kraft M, et al. Effects of treatment with anti-immunoglobulin Eantibody omalizumab on airway inflammation in allergic asthma. Am J Respir Crit Care Med. 2004; 170 (6): 583-593.
14. Busse W, Corren J, Lanier BQ, et al. Omalizumab, anti-IgE recombinant humanized monoclonal antibody, for the treatment of severe allergic asthma. J Allergy Clin Immunol. 2001; 108 (2): 184-190.
15. Solèr M, Matz J, Townley R, et al. The anti-IgE antibody omalizumab reduces exacerbations and steroid requirement in allergic asthmatics. Eur Respir J. 2001; 18 (2): 254-261.
16. Bousquet J, Cabrera P, Berkman N, et al. The effect of treatment with omalizumab, an anti-IgE antibody, on asthma exacerbations and emergency medical visits in patients with severe persistent asthma. Allergy. 2005; 60 (3): 302-308.
17. National Institutes of Health. National Asthma Education and Prevention Program. Expert Panel Report 3: Guidelines for the Diagnosis and Management of Asthma. Bethesda, MD : National Institutes of Health, National Heart, Lung, and Blood Institute; 2007 : 1-440.
18. Global strategy for asthma management and prevention 2012. Global Initiative for Asthma website. http://www.ginasthma.org. Accessed December 22, 2012.
19. Emanuel IA. In vitro testing for allergy diagnosis. O tolaryngol Clin North Am. 2003; 36 (5): 879-893.
20. Cox L, Williams B, Sicherer S, et al; American College of Allergy, Asthma and Immunology Test Task Force; American Academy of Allergy, Asthma and Immunology Specific IgE Test Task Force. Pearls and pitfalls of allergy diagnostic testing: report from the American College of Allergy, Asthma and Immunology/American Academy of Allergy, Asthma and Immunology Specific IgE Test Task Force. Ann Allergy Asthma Immunol. 2008; 101 (6): 580-592.
21. Bernstein IL, Li JT, Bernstein DI, et al; American Academy of Allergy, Asthma and Immunology; American College of Allergy, Asthma and Immunology. Allergy diagnostic testing: an updated practice parameter. Ann Allergy Asthma Immunol. 2008; 100 (3 suppl 3): S1 - S148.
22. Skin allergy testing form completed example. Joint Council Allergy, Asthma & Immunology website. http://www.aaaai.org/Aaaai/media/MediaLibrary/PDF%20Documents/Immunotherapy%20Forms/Skin%20Allergy%20Testing/1c-2011-completed-skin-test.pdf. Accessed September 10, 2014.
23. Department of Health and Human Services. Program memorandum carriers, transmittal B-01-28. Physician supervision of diagnostic tests. CMS website. https://www.cms.gov/Regulations-and-Guidance/Guidance/Transmittals/downloads/B0128.pdf. Accessed September 10, 2014.
24. Hamilton RG, Franklin Adkinson N Jr. In vitro assays for the diagnosis of IgE-mediated disorders. J Allergy Clin Immunol. 2004; 114 (2): 213-225.
25. Hamilton RG. Accuracy of US Food and Drug Administration cleared IgE antibody assays in the presence of anti-IgE (omalizumab). J Allergy Clin Immunol. 2006; 117 (4): 759-766.
26. Hamilton RG, Adkinson NF Jr. 23. Clinical laboratory assessment of IgE-dependent hypersensitivity. J Allergy Clin Immunol. 2003; 111 (2 suppl 2): S687 - S701.
27. Immuno CAP specific IgE blood test regional profiles. Quest Diag nostics website. https://www.questdiagnostics.com/home/physicians/testing-services/by-test-name/immunocap/immunocap-reg-profile.html. Accessed September 11, 2014.
28. Kerkhof M, Dubois AE, Postma DS, Schouten JP, de Monchy JG. Role and interpretation of total serum IgE measurements in the diagnosis of allergic airway disease in adults. Allergy. 2003; 58 (9): 905-911.
29. Sarpong SB, Karrison T. Skin test reactivity to indoor allergens as a marker of asthma severity in children with asthma. Ann Allergy Asthma Immunol. 1998; 80 (4): 303-308.
30. Akerman M, Valentine-Maher S, Rao M, et al. Allergen sensitivity and asthma severity at an inner city asthma center. J Asthma. 2003; 40 (1): 55-62.
31. Tunnicliffe WS, Fletcher TJ, Hammond K, et al. Sensitivity and exposure to indoor allergens in adults with differing asthma severity. Eur Respir J. 1999; 13 (3): 654-659.
32. Chinoy B, Yee E, Bahna SL. Skin testing versus radioallergosorbent testing for indoor allergens. Clin Mol Allergy. 2005; 3 (1): 4.
33. Eggleston PA. Improving indoor environments: reducing allergen exposures. J Allergy Clin Immunol. 2005; 116 (1): 122-126.
34. Bousquet J, Anto JM, Bachert C, et al. Factors responsible for differences between asymptomatic subjects and patients presenting an IgE sensitization to allergens. A GA2LEN project. Allergy. 2006; 61 (6): 671-680.
35. Claims processing manual, chapter 12, section 30.6.1B. Centers for Medicare & Medicaid Services website. http://www.cms.gov/Regulations-and-Guidance/Guidance/Manuals/Downloads/clm104c12.pdf. Accessed on September 10, 2014.
36. Anthem network update, 2008. Anthem Blue Cross and Blue Shield website. http://www.anthem.com/provider/va/f5/s1/t0/pw-ad092952.pdf. Accessed September 26, 2013.
37. Medicare Part A. Omalizumab (Xolair®), J2357, coverage. Noridian Healthcare Solutions website. https://www.noridianmedicare.com/cgi-bin/coranto/viewnews.cgi?id 5 EFFpyAZEppQwhAvvZG& tmpl 5 part-a-viewnews&style 5 part-ab-viewnews. Accessed September 10, 2014.
38. Xolair administration billing update, 2011. Gateway Health Plan website. http://www.gatewayhealthplan.com/documents/XOLAIR.pdf. Accessed on September 26, 2013.
39. Blue review: Coding alert for the administration of Xolair. BlueCross BlueShield of Illinois website. http://www.bcbsil.com/PDF/bluereview/may-2010.pdf. Accessed on September 26, 2013.